Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?

Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alcohol and alcoholism (Oxford) 2018-03, Vol.53 (2), p.187-192
Hauptverfasser: Wieland, Amanda, Everson, Gregory T
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 192
container_issue 2
container_start_page 187
container_title Alcohol and alcoholism (Oxford)
container_volume 53
creator Wieland, Amanda
Everson, Gregory T
description Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant. Abstract Aims To provide an overview of published literature on the interaction of alcohol and hepatitis C virus (HCV) in the accelerated progression of liver disease to cirrhosis as relates to decision-making for the management of the liver transplant candidate and recipient. Methods General PubMed search was employed along with expert input to identify the relevant articles on the topic. The authors also utilized both backward and forward citation review of the relevant articles and reviews to identify articles on identified topic. Results In HCV cases, heavy alcohol use has been associated with more severe fibrosis, but even low rates of use may have deleterious effects. Patients with chronic hepatitis C and alcoholic liver disease can be cured of the HCV—theoretically positively impacting outcome and reducing the need for liver transplantation. Current antiviral therapy achieves virologic cure or sustained viral response (SVR) in over 90% of cases. Antiviral therapy is so effective that most liver transplant candidates or recipients can be cured of HCV either prior to or after transplantation. However, despite successful antiviral therapy, liver disease may progress after SVR due to the effects of ongoing alcohol use. Conclusion Antiviral therapy in patients with HCV plus alcohol should improve pre- and post-transplant outcomes, but providers must remain firm in limiting use of alcohol to avoid progression of liver disease post HCV cure. Short Summary Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant.
doi_str_mv 10.1093/alcalc/agx101
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_alcalc_agx101</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/alcalc/agx101</oup_id><sourcerecordid>10.1093/alcalc/agx101</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-67e6d82f0c79feae058ba42fc0aaf1f5ba64dfc57df252be6cd6ea67eac09fb43</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EouVjZEUeWUzt2EkaFlSFj1aqxFLm6OLYrVFqR3aKyr_HJYUV6ZXupHveGx6Ebhi9Z7TgE2hlzATWe0bZCRozkQnCU5qcojHNeUqoYGKELkL4oJQJnrBzNEoKHpPzMdqUjqi9Cb2xazxXHfSmNwGXGGyDZ610G9caiZfmU3n8ZIKCoB7wLK5bY03YHGoL2xgZi85i7fyRXXmwoWvB9j-Xxyt0pqEN6vo4L9H7y_OqnJPl2-uinC2J5AXrSZarrJkmmsq80AoUTac1iERLCqCZTmvIRKNlmjc6SZNaZbLJFMQWSFroWvBLRIa_0rsQvNJV580W_FfFaHUwVg3GqsFY5G8HvtvVW9X80b-KInA3AG7X_fPrGzrFeR4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Wieland, Amanda ; Everson, Gregory T</creator><creatorcontrib>Wieland, Amanda ; Everson, Gregory T</creatorcontrib><description>Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant. Abstract Aims To provide an overview of published literature on the interaction of alcohol and hepatitis C virus (HCV) in the accelerated progression of liver disease to cirrhosis as relates to decision-making for the management of the liver transplant candidate and recipient. Methods General PubMed search was employed along with expert input to identify the relevant articles on the topic. The authors also utilized both backward and forward citation review of the relevant articles and reviews to identify articles on identified topic. Results In HCV cases, heavy alcohol use has been associated with more severe fibrosis, but even low rates of use may have deleterious effects. Patients with chronic hepatitis C and alcoholic liver disease can be cured of the HCV—theoretically positively impacting outcome and reducing the need for liver transplantation. Current antiviral therapy achieves virologic cure or sustained viral response (SVR) in over 90% of cases. Antiviral therapy is so effective that most liver transplant candidates or recipients can be cured of HCV either prior to or after transplantation. However, despite successful antiviral therapy, liver disease may progress after SVR due to the effects of ongoing alcohol use. Conclusion Antiviral therapy in patients with HCV plus alcohol should improve pre- and post-transplant outcomes, but providers must remain firm in limiting use of alcohol to avoid progression of liver disease post HCV cure. Short Summary Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant.</description><identifier>ISSN: 0735-0414</identifier><identifier>EISSN: 1464-3502</identifier><identifier>DOI: 10.1093/alcalc/agx101</identifier><identifier>PMID: 29329373</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><ispartof>Alcohol and alcoholism (Oxford), 2018-03, Vol.53 (2), p.187-192</ispartof><rights>The Author 2018. Medical Council on Alcohol and Oxford University Press. All rights reserved. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-67e6d82f0c79feae058ba42fc0aaf1f5ba64dfc57df252be6cd6ea67eac09fb43</citedby><cites>FETCH-LOGICAL-c391t-67e6d82f0c79feae058ba42fc0aaf1f5ba64dfc57df252be6cd6ea67eac09fb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29329373$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wieland, Amanda</creatorcontrib><creatorcontrib>Everson, Gregory T</creatorcontrib><title>Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?</title><title>Alcohol and alcoholism (Oxford)</title><addtitle>Alcohol Alcohol</addtitle><description>Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant. Abstract Aims To provide an overview of published literature on the interaction of alcohol and hepatitis C virus (HCV) in the accelerated progression of liver disease to cirrhosis as relates to decision-making for the management of the liver transplant candidate and recipient. Methods General PubMed search was employed along with expert input to identify the relevant articles on the topic. The authors also utilized both backward and forward citation review of the relevant articles and reviews to identify articles on identified topic. Results In HCV cases, heavy alcohol use has been associated with more severe fibrosis, but even low rates of use may have deleterious effects. Patients with chronic hepatitis C and alcoholic liver disease can be cured of the HCV—theoretically positively impacting outcome and reducing the need for liver transplantation. Current antiviral therapy achieves virologic cure or sustained viral response (SVR) in over 90% of cases. Antiviral therapy is so effective that most liver transplant candidates or recipients can be cured of HCV either prior to or after transplantation. However, despite successful antiviral therapy, liver disease may progress after SVR due to the effects of ongoing alcohol use. Conclusion Antiviral therapy in patients with HCV plus alcohol should improve pre- and post-transplant outcomes, but providers must remain firm in limiting use of alcohol to avoid progression of liver disease post HCV cure. Short Summary Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant.</description><issn>0735-0414</issn><issn>1464-3502</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAQhi0EouVjZEUeWUzt2EkaFlSFj1aqxFLm6OLYrVFqR3aKyr_HJYUV6ZXupHveGx6Ebhi9Z7TgE2hlzATWe0bZCRozkQnCU5qcojHNeUqoYGKELkL4oJQJnrBzNEoKHpPzMdqUjqi9Cb2xazxXHfSmNwGXGGyDZ610G9caiZfmU3n8ZIKCoB7wLK5bY03YHGoL2xgZi85i7fyRXXmwoWvB9j-Xxyt0pqEN6vo4L9H7y_OqnJPl2-uinC2J5AXrSZarrJkmmsq80AoUTac1iERLCqCZTmvIRKNlmjc6SZNaZbLJFMQWSFroWvBLRIa_0rsQvNJV580W_FfFaHUwVg3GqsFY5G8HvtvVW9X80b-KInA3AG7X_fPrGzrFeR4</recordid><startdate>20180301</startdate><enddate>20180301</enddate><creator>Wieland, Amanda</creator><creator>Everson, Gregory T</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180301</creationdate><title>Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?</title><author>Wieland, Amanda ; Everson, Gregory T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-67e6d82f0c79feae058ba42fc0aaf1f5ba64dfc57df252be6cd6ea67eac09fb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wieland, Amanda</creatorcontrib><creatorcontrib>Everson, Gregory T</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Alcohol and alcoholism (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wieland, Amanda</au><au>Everson, Gregory T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?</atitle><jtitle>Alcohol and alcoholism (Oxford)</jtitle><addtitle>Alcohol Alcohol</addtitle><date>2018-03-01</date><risdate>2018</risdate><volume>53</volume><issue>2</issue><spage>187</spage><epage>192</epage><pages>187-192</pages><issn>0735-0414</issn><eissn>1464-3502</eissn><abstract>Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant. Abstract Aims To provide an overview of published literature on the interaction of alcohol and hepatitis C virus (HCV) in the accelerated progression of liver disease to cirrhosis as relates to decision-making for the management of the liver transplant candidate and recipient. Methods General PubMed search was employed along with expert input to identify the relevant articles on the topic. The authors also utilized both backward and forward citation review of the relevant articles and reviews to identify articles on identified topic. Results In HCV cases, heavy alcohol use has been associated with more severe fibrosis, but even low rates of use may have deleterious effects. Patients with chronic hepatitis C and alcoholic liver disease can be cured of the HCV—theoretically positively impacting outcome and reducing the need for liver transplantation. Current antiviral therapy achieves virologic cure or sustained viral response (SVR) in over 90% of cases. Antiviral therapy is so effective that most liver transplant candidates or recipients can be cured of HCV either prior to or after transplantation. However, despite successful antiviral therapy, liver disease may progress after SVR due to the effects of ongoing alcohol use. Conclusion Antiviral therapy in patients with HCV plus alcohol should improve pre- and post-transplant outcomes, but providers must remain firm in limiting use of alcohol to avoid progression of liver disease post HCV cure. Short Summary Abusive alcohol use and chronic hepatitis C virus (HCV) commonly co-exist and both need to be addressed in liver disease. With high rates of HCV cure with new therapies, attention needs to turn toward ongoing abusive alcohol patterns that may determinately impact liver health both before and after liver transplant.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>29329373</pmid><doi>10.1093/alcalc/agx101</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0735-0414
ispartof Alcohol and alcoholism (Oxford), 2018-03, Vol.53 (2), p.187-192
issn 0735-0414
1464-3502
language eng
recordid cdi_crossref_primary_10_1093_alcalc_agx101
source Oxford University Press Journals All Titles (1996-Current); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Co-existing Hepatitis C and Alcoholic Liver Disease: A Diminishing Indication for Liver Transplantation?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T19%3A29%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Co-existing%20Hepatitis%20C%20and%20Alcoholic%20Liver%20Disease:%20A%20Diminishing%20Indication%20for%20Liver%20Transplantation?&rft.jtitle=Alcohol%20and%20alcoholism%20(Oxford)&rft.au=Wieland,%20Amanda&rft.date=2018-03-01&rft.volume=53&rft.issue=2&rft.spage=187&rft.epage=192&rft.pages=187-192&rft.issn=0735-0414&rft.eissn=1464-3502&rft_id=info:doi/10.1093/alcalc/agx101&rft_dat=%3Coup_cross%3E10.1093/alcalc/agx101%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/29329373&rft_oup_id=10.1093/alcalc/agx101&rfr_iscdi=true